264 related articles for article (PubMed ID: 19126872)
1. Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.
Giblin W; Chatterji M; Westfield G; Masud T; Theisen B; Cheng HL; DeVido J; Alt FW; Ferguson DO; Schatz DG; Sekiguchi J
Blood; 2009 Mar; 113(13):2965-75. PubMed ID: 19126872
[TBL] [Abstract][Full Text] [Related]
2. A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.
Jacobs C; Huang Y; Masud T; Lu W; Westfield G; Giblin W; Sekiguchi JM
Hum Mol Genet; 2011 Feb; 20(4):806-19. PubMed ID: 21147755
[TBL] [Abstract][Full Text] [Related]
3. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
[TBL] [Abstract][Full Text] [Related]
4. Signal joint formation is inhibited in murine scid preB cells and fibroblasts in substrates with homopolymeric coding ends.
Sun T; Ezekiel UR; Erskine L; Agulo R; Bozek G; Roth D; Storb U
Mol Immunol; 1999 Jun; 36(8):551-8. PubMed ID: 10475610
[TBL] [Abstract][Full Text] [Related]
5. Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.
Horowitz JE; Bassing CH
J Immunol; 2014 Feb; 192(4):1609-19. PubMed ID: 24415779
[TBL] [Abstract][Full Text] [Related]
6. Catalytic RAG1 mutants obstruct V(D)J recombination in vitro and in vivo.
Furusawa T; Hosoe M; Ohkoshi K; Takahashi S; Kiyokawa N; Fujimoto J; Amemiya H; Suzuki S; Tokunaga T
Mol Immunol; 2003 May; 39(14):871-8. PubMed ID: 12686503
[TBL] [Abstract][Full Text] [Related]
7. Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.
Brauer PM; Pessach IM; Clarke E; Rowe JH; Ott de Bruin L; Lee YN; Dominguez-Brauer C; Comeau AM; Awong G; Felgentreff K; Zhang YH; Bredemeyer A; Al-Herz W; Du L; Ververs F; Kennedy M; Giliani S; Keller G; Sleckman BP; Schatz DG; Bushman FD; Notarangelo LD; Zúñiga-Pflücker JC
Blood; 2016 Aug; 128(6):783-93. PubMed ID: 27301863
[TBL] [Abstract][Full Text] [Related]
8. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
[TBL] [Abstract][Full Text] [Related]
9. N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements.
Noordzij JG; Verkaik NS; Hartwig NG; de Groot R; van Gent DC; van Dongen JJ
Blood; 2000 Jul; 96(1):203-9. PubMed ID: 10891452
[TBL] [Abstract][Full Text] [Related]
10. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
Nacht M; Jacks T
Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination.
Landree MA; Wibbenmeyer JA; Roth DB
Genes Dev; 1999 Dec; 13(23):3059-69. PubMed ID: 10601032
[TBL] [Abstract][Full Text] [Related]
12. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
[TBL] [Abstract][Full Text] [Related]
13. RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
Petiniot LK; Weaver Z; Vacchio M; Shen R; Wangsa D; Barlow C; Eckhaus M; Steinberg SM; Wynshaw-Boris A; Ried T; Hodes RJ
Mol Cell Biol; 2002 May; 22(9):3174-7. PubMed ID: 11940674
[TBL] [Abstract][Full Text] [Related]
14. Activation of V(D)J recombination induces the formation of interlocus joints and hybrid joints in scid pre-B-cell lines.
Lew S; Franco D; Chang Y
Mol Cell Biol; 2000 Oct; 20(19):7170-7. PubMed ID: 10982833
[TBL] [Abstract][Full Text] [Related]
15. Compound heterozygous mutation of Rag1 leading to Omenn syndrome.
Matthews AG; Briggs CE; Yamanaka K; Small TN; Mooster JL; Bonilla FA; Oettinger MA; Butte MJ
PLoS One; 2015; 10(4):e0121489. PubMed ID: 25849362
[TBL] [Abstract][Full Text] [Related]
16. Evidence of a critical architectural function for the RAG proteins in end processing, protection, and joining in V(D)J recombination.
Tsai CL; Drejer AH; Schatz DG
Genes Dev; 2002 Aug; 16(15):1934-49. PubMed ID: 12154124
[TBL] [Abstract][Full Text] [Related]
17. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice.
Chiu PP; Ivakine E; Mortin-Toth S; Danska JS
Cancer Res; 2002 Oct; 62(20):5828-34. PubMed ID: 12384545
[TBL] [Abstract][Full Text] [Related]
19. Impact of a hypomorphic Artemis disease allele on lymphocyte development, DNA end processing, and genome stability.
Huang Y; Giblin W; Kubec M; Westfield G; St Charles J; Chadde L; Kraftson S; Sekiguchi J
J Exp Med; 2009 Apr; 206(4):893-908. PubMed ID: 19349461
[TBL] [Abstract][Full Text] [Related]
20. Impaired V(D)J recombination and lymphocyte development in core RAG1-expressing mice.
Dudley DD; Sekiguchi J; Zhu C; Sadofsky MJ; Whitlow S; DeVido J; Monroe RJ; Bassing CH; Alt FW
J Exp Med; 2003 Nov; 198(9):1439-50. PubMed ID: 14581608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
